Preliminary experience and outcomes of transoral robotic surgery for hypopharyngeal cancer
10.3760/cma.j.cn115330-20240803-00459
- VernacularTitle:经口机器人手术治疗下咽癌的初步经验
- Author:
Ping HAN
1
;
Xiaoming HUANG
;
Chengzhi XU
;
Lei TAO
;
Huijun YANG
;
Longjuan CHU
;
Yinhao LIU
;
Kai XU
;
Xiang LU
Author Information
1. 中山大学孙逸仙纪念医院耳鼻咽喉科 广东省恶性肿瘤表观遗传与基因调控重点实验室，广州 510280
- Publication Type:Journal Article
- Keywords:
Head and neck neoplasms;
Hypopharyngeal carcinoma;
Transoral robotic surgery;
Minimally invasive surgery
- From:
Chinese Journal of Otorhinolaryngology Head and Neck Surgery
2025;60(3):272-277
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To summarize preliminary experience and outcomes of transoral robotic surgery (TORS) in hypopharyngeal cancer.Methods:Clinical data of 28 patients with hypopharyngeal cancer underwent TORS with Da Vinci Si or Xi surgical system in three medical centers(Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University and Eye & ENT Hospital of Fudan University) in China from Sep 2017 to Mar 2024 were respectively analyzed. All patients were males, aged from 47 to 82(62.5±7.1) years old. According to TNM staging of AJCC, the stages included T1 in 6 cases, T2 in 17 cases, T3 in 3 cases and T4 in 2 cases; N0 in 18 cases, N1 in 3 cases, N2 in 6 cases, N3 in 1 case. SPSS version 26 was applied, and with Kaplan-Meier surviving curves, overall survival, local control rate and disease-free survival for those patients were calculated.Results:All 28 patients underwent successfully their TORS, no any case with transfer opening or positive surgical margin. Two patients died within one month after surgery. Two patients experienced minor oral bleeding, and subsenquently was cured. The follow-up period ranged from 1 to 81 months, with an average of 24.8 months, in which, five patients(17.9%) died, five patients(17.9%) experienced local recurrence and four patients(14.3%) had distant metastases. The three year overall survival, local control rate and disease-free survival were 77.1%, 74.6% and 57.1%, respectively.Conclusion:In properly selected cases of hypopharyngeal cancer, TORS can offer acceptable survival and local control rates, which can be considered as a new useful option for the surgery of hypopharyngeal cancer.
